CA2552112A1 - Protein detection system - Google Patents
Protein detection system Download PDFInfo
- Publication number
- CA2552112A1 CA2552112A1 CA 2552112 CA2552112A CA2552112A1 CA 2552112 A1 CA2552112 A1 CA 2552112A1 CA 2552112 CA2552112 CA 2552112 CA 2552112 A CA2552112 A CA 2552112A CA 2552112 A1 CA2552112 A1 CA 2552112A1
- Authority
- CA
- Canada
- Prior art keywords
- protein
- phloxine
- sample
- method recited
- sequestering agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002331 protein detection Methods 0.000 title claims description 6
- GVKCHTBDSMQENH-UHFFFAOYSA-L phloxine B Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GVKCHTBDSMQENH-UHFFFAOYSA-L 0.000 claims abstract description 67
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 52
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 52
- 210000002700 urine Anatomy 0.000 claims abstract description 38
- 241001465754 Metazoa Species 0.000 claims abstract description 21
- 230000008859 change Effects 0.000 claims abstract description 20
- 239000003352 sequestering agent Substances 0.000 claims abstract description 20
- 230000010874 maintenance of protein location Effects 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 241000282324 Felis Species 0.000 claims abstract description 13
- 239000000654 additive Substances 0.000 claims abstract description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 23
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 18
- 239000000741 silica gel Substances 0.000 claims description 14
- 229910002027 silica gel Inorganic materials 0.000 claims description 14
- 239000002250 absorbent Substances 0.000 claims description 9
- 230000002745 absorbent Effects 0.000 claims description 9
- 239000004927 clay Substances 0.000 claims description 8
- 235000012216 bentonite Nutrition 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 7
- ZPIMPPJEDUQYEW-UHFFFAOYSA-N 2-dodecyl-5-(4-sulfophenoxy)benzenesulfonic acid Chemical group C1=C(S(O)(=O)=O)C(CCCCCCCCCCCC)=CC=C1OC1=CC=C(S(O)(=O)=O)C=C1 ZPIMPPJEDUQYEW-UHFFFAOYSA-N 0.000 claims description 6
- 230000000903 blocking effect Effects 0.000 claims description 5
- 239000001509 sodium citrate Substances 0.000 claims description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 5
- 229960000892 attapulgite Drugs 0.000 claims description 4
- 229910052625 palygorskite Inorganic materials 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 229910021532 Calcite Inorganic materials 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 239000010459 dolomite Substances 0.000 claims description 3
- 229910000514 dolomite Inorganic materials 0.000 claims description 3
- 239000010440 gypsum Substances 0.000 claims description 3
- 229910052602 gypsum Inorganic materials 0.000 claims description 3
- 235000019362 perlite Nutrition 0.000 claims description 3
- 239000010457 zeolite Substances 0.000 claims description 3
- 241000282465 Canis Species 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims description 2
- 241000282414 Homo sapiens Species 0.000 claims description 2
- 239000005909 Kieselgur Substances 0.000 claims description 2
- 241000283984 Rodentia Species 0.000 claims description 2
- 239000004113 Sepiolite Substances 0.000 claims description 2
- HPTYUNKZVDYXLP-UHFFFAOYSA-N aluminum;trihydroxy(trihydroxysilyloxy)silane;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O[Si](O)(O)O HPTYUNKZVDYXLP-UHFFFAOYSA-N 0.000 claims description 2
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 claims description 2
- 229910052570 clay Inorganic materials 0.000 claims description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 2
- 229910000286 fullers earth Inorganic materials 0.000 claims description 2
- 229910052621 halloysite Inorganic materials 0.000 claims description 2
- 229910000271 hectorite Inorganic materials 0.000 claims description 2
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 claims description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052622 kaolinite Inorganic materials 0.000 claims description 2
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 2
- 239000008262 pumice Substances 0.000 claims description 2
- 229910052624 sepiolite Inorganic materials 0.000 claims description 2
- 235000019355 sepiolite Nutrition 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 239000010454 slate Substances 0.000 claims description 2
- 229910021647 smectite Inorganic materials 0.000 claims description 2
- 239000010455 vermiculite Substances 0.000 claims description 2
- 229910052902 vermiculite Inorganic materials 0.000 claims description 2
- 235000019354 vermiculite Nutrition 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims 1
- 241000283073 Equus caballus Species 0.000 claims 1
- 241000219745 Lupinus Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 15
- 229940098773 bovine serum albumin Drugs 0.000 description 15
- 239000000243 solution Substances 0.000 description 14
- 230000036541 health Effects 0.000 description 13
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 11
- 229960004106 citric acid Drugs 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 239000000440 bentonite Substances 0.000 description 5
- 229910000278 bentonite Inorganic materials 0.000 description 5
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 241000282326 Felis catus Species 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 0 BC(C(C(B)=C1Oc2c3cc(B)c(O)c2B)O)=CC1=C3c1c(*)c([U])c(*)c(I=I)c1CO Chemical compound BC(C(C(B)=C1Oc2c3cc(B)c(O)c2B)O)=CC1=C3c1c(*)c([U])c(*)c(I=I)c1CO 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- YCPXWRQRBFJBPZ-UHFFFAOYSA-N 5-sulfosalicylic acid Chemical compound OC(=O)C1=CC(S(O)(=O)=O)=CC=C1O YCPXWRQRBFJBPZ-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000699694 Gerbillinae Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000010828 animal waste Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010881 fly ash Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- -1 i.e. Chemical compound 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 239000007793 ph indicator Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K1/00—Housing animals; Equipment therefor
- A01K1/015—Floor coverings, e.g. bedding-down sheets ; Stable floors
- A01K1/0152—Litter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
- B01J20/103—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate comprising silica
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
- B01J20/12—Naturally occurring clays or bleaching earth
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/528—Atypical element structures, e.g. gloves, rods, tampons, toilet paper
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Environmental Sciences (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Geochemistry & Mineralogy (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
A system for detecting protein in mammalian urine is disclosed herein.
Phloxine B buffered between pH 2-2.5 undergoes a color change from colorless to red in the presence of protein. Disclosed herein are animal litter compositions and additives comprising Phloxine B and a protein-sequestering agent buffered at a pH
below about 3 which detect the presence of protein at levels indicative of ill-health in feline urine.
Phloxine B buffered between pH 2-2.5 undergoes a color change from colorless to red in the presence of protein. Disclosed herein are animal litter compositions and additives comprising Phloxine B and a protein-sequestering agent buffered at a pH
below about 3 which detect the presence of protein at levels indicative of ill-health in feline urine.
Description
' = CA 02552112 2006-07-12 PATENT
DOCKET NO: 430.204 PROTEIN DETECTION SYSTEM
Inventors: Dennis B. Jenkins, Edward B. Tucker and Timothy E. Kozikoski FIELD OF THE INVENTION
[00011 The present invention relates generally to protein detection. In particular detection of protein in feline urine is discussed.
BACKGROUND OF THE INVENTION
DOCKET NO: 430.204 PROTEIN DETECTION SYSTEM
Inventors: Dennis B. Jenkins, Edward B. Tucker and Timothy E. Kozikoski FIELD OF THE INVENTION
[00011 The present invention relates generally to protein detection. In particular detection of protein in feline urine is discussed.
BACKGROUND OF THE INVENTION
[0002] The presence of protein in certain bodily fluids can be an indication of illness.
For example, the presence of elevated protein levels in feline urine can indicate kidney disease, a significant cause of cat illness and death.
SUNIMARY OF THE INVENTION
100031 An aspect of the invention includes an animal litter additive comprising: MB
Macroporous silica gel buffered at a pH below about 3 containing a mixture of a protein-sequestering agent and Phloxine, wherein said protein-sequestering agent is present in an amount effective at blocking the attachment of Phloxine to protein at a predetenmined protein level.
[0004] Another aspect of the invention includes a protein detection method comprising: providing a sample; contacting said sample with Phloxine; and detecting the presence of protein in said sample, wherein a color change is observed if said sample contains said protein.
[0005] A further aspect of the invention includes an animal litter comprising:
an absorbent material suitable for use as an animal litter, wherein at least a portion of said litter contains Phloxine, wherein said Phloxine-containing portion of litter is below about pH3.
BRIEF DESCRIPTION OF THE DRAWINGS
[0006] Further features and advantages will become apparent from the following accompanying drawings.
[0007] FIG. 1 shows the chemical structure of unbound Phloxine (colorless) and bound Phloxine (pink).
The Clorox Company 1 430.204 r 1r x . - r . N x .. d n 1, [0008] FIG. 2 shows a mechanism by which Phloxine attaches to protein.
[0009] FIG. 3 illustrates a mechanism by which a protein sequestering agent inhibits the attachment of Phloxine to protein.
DETAILED DESCRIPTION OF THE INVENTION
[0010] Protein levels in mammalian bodily fluids can be indicators of disease.
The ability to detect these proteins in samples of various mammalian urine is disclosed herein. Bovine serum albumin is used as a representative protein to evaluate the various detection embodiments disclosed herein. The methods of the present invention are effective for detecting protein in urine samples from mammals, e.g., humans, felines, canines, and rodents. The animal litter disclosed herein could be used for common pets, cats, dogs, gerbils, guinea pigs, mice and hamsters, rabbits, ferrets and laboratory animals (e.g., mice, rats, and the like).
100111 Disclosed herein is the use of Phloxine B, i.e., Acid Red 92 (CAS NO.
87-2, C2oH2Br4Cl 4Na2O5. MOL WT. 829.64), hereinafter referred to as Phloxine, as a protein detector. Phloxine is a pH indicator that undergoes a visual color change based on it's pKa. Referring to FIG. 1, Phloxine goes from colorless (left) to red (right) between about pH 2-3.3, i.e., Phloxine is colorless below about pH 2, red above about pH 3.3 and varying shades of pink (pale to dark) between about pH
2-3.3.
FIG. 2 shows a mechanism by which Phloxine attaches to protein thereby causing a color change from colorless (unbound) to red (bound) without a pH change. The pKa of unbound Phloxine occurs at about pH 2.8-2.9, if Phloxine is bound to a protein, the pKa shifts to the lower pH value of about 2 -2.2. In a buffered system, this pKa shift changes the color of the indicator without a commensurate change in the pH.
Unbound Phloxine will appear colorless at pH levels between about 2.3-3, whereas The Clorox Company 2 430.204 " CA 02552112 2006-07-12 [0012] Phloxine bound to protein will appear pink at pH levels between about 2.3 - 3.
Thus, buffering a sample at a pH below about 3 and contacting that sample with Phloxine enables the presence of protein to be detected in the sample via a color change from colorless to red. Optimally, the final combination of sample and Phloxine will result in a pH between about 2 and 2.5. Thus, depending on the conditions surrounding the Phloxine, the optimal buffering pH may vary, but should be below about 3.
[0013] Colorless to red as used herein means colorless to the entire spectrum of pink and red, including any and all shades of pink and red. Red shade color shifts are also possible if the starting color is something other than colorless. For example, if the starting color is blue, a red shade color shift to purple would be observed.
Test strips containing Phloxine can be prepared by wetting a suitable paper substrate with a Phloxine solution and drying. Such test strips would be useful to those in the medical field.
Detection of protein in feline urine [0014] Disclosed herein is the incorporation of a health indicating system into an animal litter. Animal litters have been used for decades as an effective way of managing the sanitation and odor control of waste. Since animal health monitoring often involves the testing of waste materials from the animal, it would be desirable to combine a health monitoring system with an animal litter. Problems associated with developing such a system are unique in that the animal waste material has to be tested "as is", i.e., without the benefit of any sample preparation or "clean-up".
For example, protein-indicating strips exist, but there are a number of limitations that prevent this technology from being used in an animal litter. Specific limitations with The Clorox Company 3 430.204 .. . , l . , I d ., I =
existing protein-indicating test strips include the following. (1) Stability of the indicator. Many protein-indicating compounds are not stable in the presence of elevated temperature, oxygen or moisture. (2) Stability of the color change.
Many indicators do not hold the color change for long periods or when dry. Thus, a color change may occur without alerting the animal owner. (3) Color contrast. Many indicating systems rely on a subtle shift in the shade of a color, creating a system that is difficult for the user to interpret.
[0015] Accompanying the fact that the waste material must be used "as is", is the fact that feline urine, itself, is unique in several aspects. Feline urine contains high levels of salt. Thus, in inadequately buffered systems, the high salt content and the highly buffering nature of feline urine tends to overwhelm these systems creating numerous false positives. The gradual changes in color that result from inadequately buffered systems are difficult for the user to detect. Furthermore, the urine of healthy cats can contain some protein. Thus, the detection of protein in feline urine can only be an indicator of cat health if (1) normal levels of protein (500 ppm) can be distinguished from disease levels (2000 ppm) and (2) the color change can be easily interpreted.
For applications of Phloxine as an indicator of feline health, color changes from colorless to pink rather than red are preferred by users. Thus, much of the discussion will revolve around systems exhibiting color changes from colorless to pink.
However, it should be noted that, if desired, systems having color changes from colorless to red could readily be designed and substituted for those of colorless to pink.
[0016] Disclosed herein is a stable health indicating system which allows for the detection of protein in feline urine using an easily interpretable colorless to pink color The Clorox Company 4 430.204 . . . , ! .. ,. . ! a i change. Although the disclosure and examples focus on feline urine, as discussed previously, the system is applicable to mammalian urine in general. A protein sequestering agent, e.g., dodecyl(sulfophenoxy)benzenesulfonic acid (hereinafter DSB), is used to inhibit the color change at low levels of protein and allow the color change at higher levels. DSB competes strongly with the Phloxine for active sites on the protein and therefore, if present in a predetermined amount, the level of protein detection can be controlled. Referring to FIG. 3, DSB works by inhibiting the attachment of the Phloxine molecule to the active sites on the protein molecule thereby inhibiting a color change from occurring. Since the sequestering agent is present at a fixed level, it is effective in blocking attachment at low levels of protein, but at higher levels of protein free sites become available for the Phloxine to occupy, thus allowing the color change to occur. Compounds believed to denature proteins (as opposed to binding to them as DSB) could be used in place of the sequestering agent.
Some examples of include Tritari surfactant, Nacconor, and 5-sulfosalicylic acid.
[0017] Stock buffer solutions of citric acid which sometimes also contain sodium citrate (ranging from about 0.5-2.5M citric acid) can be used in preparing phloxine/DSB litter compositions as discussed in the Examples herein. Both Phloxine and DSB are very stable, i.e., no refrigeration is required and shelf life is not limited.
[0018] All or a portion of an absorbent litter material is coated or imbedded with the Phloxine/protein sequestering agent composition described. The Phloxine/protein sequestering agent composition can be added to the litter as a liquid spray, a powder coating or ingredient, a precoated particle, a speckle, or as part of an agglomerate litter. Suitable absorbent litter materials include minerals, fly ash, absorbing pelletized materials, perlite, silicas, other absorbent materials and mixtures thereof.
The Clorox Company 5 430.204 . .,l . , . ..I . ,.~. .. 4 , = CA 02552112 2006-07-12 Preferred minerals include: bentonites, zeolites, fullers earth, attapulgite, montmorillonite diatomaceous earth, opaline silica, Georgia White clay, sepiolite, calcite, dolomite, slate, pumice, tobermite, marls, attapulgite, kaolinite, halloysite, smectite, vermiculite, hectorite, Fuller's earth, fossilized plant materials, expanded perlites, gypsum and other similar minerals and mixtures thereof. The absorbent materials can be further processed, for instance by agglomeration. The lower the intrinsic pH of the substrate, the lower the amount of buffering agent needed.
Thus, substrates having intrinsically low pHs relative to other substrates are preferred.
When contacted with the animal urine, the Phloxine/protein sequestering agent composition changes to a color in the presence of high levels of protein and stays colorless in the absence of protein or in the presence of low levels of protein.
Additional base colorants can be added to create a color change from one color to another color of a redder shade (e.g., blue to purple, etc.). Filler materials such as limestone, sand, calcite, dolomite, recycled waste materials, zeolites, and gypsum can also be incorporated with the absorbent materials to reduce the cost of the litter without significantly decreasing the material's perfonmance as a health indicating litter.
[0019] Partial treatment of the litter can be accomplished by incorporating "treated speckles" into the base litter composition. Some problems associated with identifying effective speckle formulations include lack of color development, spontaneous color change, or bleeding of color. Effective speckle materials have the following properties: (1) Porous and rapidly absorbent; (2) Able to hold a high salt load; (3) Moderate surface area (about 25-300 m2/g) and large pore size (greater than 400A);
(4) Moderate surface acidity (pH between about 1-7) (5) Light color.
Presumably, the The Clorox Company 6 430.204 4 ..,, ... ..I ,..4.... i.
high buffer loading and the rapid absorptivity allows for less influence from outside the particle. One material which fit the above-listed criteria is large pore size silica gel or Type MB macroporous silica gel. For example, a suspension of Phloxine B
indicator, buffered at a pH of 2.1, with a trace of Rhodocal DSB-85, can be sprayed at a high loading rate (e.g., 20% or greater) onto Type MB Macroporous silica gel to form a "treated speckle". Incorporation of "treated speckles" into high pH
clays such as bentonite can be accomplished, but care should be taken to avoid the Phloxine bleeding out of the speckle particles and turning red upon contact with the bentonite.
For example, the litter can be layered to ensure that the Phloxine is bound up in an immobile layer, such as guar gum. Alternatively, a polymeric non-leaching indicator can be used in place of the Phioxine.
100201 Non-litter applications of the combination of Phloxine/protein sequestering agent are also disclosed herein. For example, test strips containing Phloxine and DSB
can be prepared and would be useful to those in the human or veterinarian medicine fields.
[0021] The following examples illustrate the present invention. The examples are for illustrative purposes only and are not meant to limit the scope of the invention in any way.
EXAMPLES
Materials [0022] Bovine serum albumin (BSA) was obtained from either EMD Pharmaceuticals or Calbiochem was used as the protein detected in all examples listed below.
BSA/water and BSA/urine standards were prepared. The urine used in BSA/urine standards was first treated by removing the native protein by precipitation with sulfosalicylic acid and filtration.
The Clorox Company 7 430.204 [0023] Phloxine was obtained from Aldrich Chemical. One percent phloxine solutions were prepared by dissolving phloxine in a small amount of methanol and then diluting with water.
[0024] The DBS used was Rhodacal DSB-85.
[0025] Stock buffer solutions of citric acid and sodium citrate can be used in preparing the phloxine/DSB litter compositions. For example, a buffer solution was prepared by adding citric acid to water and measuring the pH. Sodium citrate was then added to the citric acid solution, if necessary, until the pH reached the desired number.
Example 1(Preparation of silica gel litter and speckles) [00261 A Phloxine/Citric Acid/DSB solution comprising 0.1 % Phloxine, 0.05%
Rhodacal DSB-85, and the remainder 2M citric acid buffered with sodium citrate (adjusted to pH 2.15) was dripped on about lOOg of Macropore B silica gel until the absorption capacity of the silica gel was reached. The Phloxine/DSB-treated silica gel was then air-dried.
Example 2(Prenaration of a clumping Georgia White C1a~GWC) litter) [0027] SamQle 2A- 4g of a 1% phloxine solution and 0.077g DSB were combined with 150g of citric acid buffer (2M, pH 2). 35g were applied to 50g of GWC
using a spray gun.
[0028] Sample 2B- 2.7g of the 1% phloxine solution were added to the solution prepared in Sample A to increase the phloxine concentration to 5%. 35g of this solution were applied to 50g GWC using a spray gun.
100291 Sample 2C- 2g of the 1% phloxine solution were added to the solution prepared in Sample B to increase the phloxine concentration to 7.5%. 35g of this solution were applied to 50g GWC using a spray gun.
[0030] Sample 2D- 1.125g of the 1% phloxine solution were added to the solution prepared in Sample C to increase the phloxine concentration to 10%. 35g of this solution were applied to 50g GWC using a spray gun.
The Clorox Company 8 430.204 [0031] The GWC samples were allowed to dry for 2 days and then were tested with BSA/urine standards containing varying amounts of protein. The results are compiled in Table 1.
Table 1 700ppm BSA/urine 1200ppm BSA/urine 3200ppm BSA/urine Sample 2A off-white off-white light pink Sample 2B off-white light pink Pink Sample 2C off-white light pink Pink Sample 2D off-white light pink Pink Example 3(Preparation of silica gel litter with health indicating ipeckels) [0032] Type C silica gel with about 5% health indicating speckles was prepared and tested. Macropore B silica gel was prepared as described in Example 1 and then added to a commercial Type C silica gel litter material.
Example 4(Preparation of clay litter with health indicating speckels) [0033] A bentonite clay litter with about 3% health indicating speckles was prepared and tested. Macropore B silica gel was prepared as described in Example 1 and then added to a commercial bentonite litter material.
Example 5 (Detection of protein when contacted with sample litter) [0034] The litter sample prepared in Example 3 was placed in a tray and tested with 2 ml of base urine (low protein) and 2 ml of 10K (theoretical), 3-5K (as analyzed) BSA/urine. The samples were evaluated after 4 hours and after 24 hours. The speckles contained in the section of sample tested with base urine remained white after 4 hours and remained unchanged after 24 hours. The speckles contained in the section of sample tested with a BSA/urine standard showed a pink hue after 4 hours and remained unchanged after 24 hours.
[0035] Another sample as described in Example 3 was prepared with a larger quantity of urine, about 5 ml, and allowed to stand for one week. The speckles contained in the section of sample tested with base urine remained white. The speckles contained The Clorox Company 9 430.204 ,,l ..,,, ,.,I ,a = e CA 02552112 2006-07-12 in the section of sample tested with a BSA/urine standard contained regions of light pink and regions of bright pink. In all cases, the color was stable with little to no bleeding.
Example 6 (Detection of protein when contacted with sample litter) [0036] The sample litter prepared in Example 4 was placed in a tray and tested with 5 ml of base urine (low protein) and 5 ml of 10 K (theoretical), 3-5K (as analyzed) BSA/urine. The samples after 4 hours and after 24 hours. The speckles contained in the section of sample tested with base urine showed regions of white and pink after 4 hours and remained unchanged after 24 hours. The speckles contained in the section of sample tested with a BSA/urine standard showed a few regions of white, some regions of light pink and some regions of darker pink after 4 hours and remained unchanged after 24 hours. Due to the high alkalinity of bentonite clay, some bleeding of color was expected to occur. Thus, the speckles were only partially successful in avoiding the influence of surrounding material.
Example 7(prenaration of agglomerated health indicating clav liter) [0037] 9.1 lbs of paste was prepared by mixing 7.81bs of guar gum and 1.3 lbs of citric acid, anhydrous and a small amount of water necessary to facilitate mixing. The paste was added to a mixture of 69.91bs of Tennessee #10 Clay, 18.2 lbs of Kentucky Stone Clay, 2.71bs of citric acid (anhydrous), and 0.10 lbs Phloxine to form a litter mixture. Other similar clay materials could be substituted for the Tennessee #10 Clay and the Kentucky Stone Clay. The litter mixture was agglomerated through extrusion (or other agglomeration means) to form an agglomerated health indicating litter material.
[00381 It is to be understood that the invention described herein is not limited to particularly exemplified systems or process parameters as such may, of course, vary.
It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments of the invention only, and is not intended to limit the scope of the invention in any manner.
The Clorox Company 10 430.204 .l .. .,. .~I .~ _.. 4 = . CA 02552112 2006-07-12 [0039] All publications, patents and patent applications cited herein, are hereby incorporated by reference in their entirety to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference.
[0040] It must be noted that, as used in this specification and the appended claims, the singular forms "a," "an" and "the" include plural referents unless the content clearly dictates otherwise. Thus, for example, reference to a "buffering agent"
includes two or more such agents.
[0041] All numbers expressing quantities of ingredients, constituents, reaction conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term "about". Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the subject matter presented herein are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contain certain errors necessarily resulting from the standard deviation found in their respective testing measurements.
[0042] A number of methods and materials similar or equivalent to those described herein can be used in the practice of the present invention. Many modifications and variations are possible in light of the above teaching.
The Clorox Company 11 430.204
For example, the presence of elevated protein levels in feline urine can indicate kidney disease, a significant cause of cat illness and death.
SUNIMARY OF THE INVENTION
100031 An aspect of the invention includes an animal litter additive comprising: MB
Macroporous silica gel buffered at a pH below about 3 containing a mixture of a protein-sequestering agent and Phloxine, wherein said protein-sequestering agent is present in an amount effective at blocking the attachment of Phloxine to protein at a predetenmined protein level.
[0004] Another aspect of the invention includes a protein detection method comprising: providing a sample; contacting said sample with Phloxine; and detecting the presence of protein in said sample, wherein a color change is observed if said sample contains said protein.
[0005] A further aspect of the invention includes an animal litter comprising:
an absorbent material suitable for use as an animal litter, wherein at least a portion of said litter contains Phloxine, wherein said Phloxine-containing portion of litter is below about pH3.
BRIEF DESCRIPTION OF THE DRAWINGS
[0006] Further features and advantages will become apparent from the following accompanying drawings.
[0007] FIG. 1 shows the chemical structure of unbound Phloxine (colorless) and bound Phloxine (pink).
The Clorox Company 1 430.204 r 1r x . - r . N x .. d n 1, [0008] FIG. 2 shows a mechanism by which Phloxine attaches to protein.
[0009] FIG. 3 illustrates a mechanism by which a protein sequestering agent inhibits the attachment of Phloxine to protein.
DETAILED DESCRIPTION OF THE INVENTION
[0010] Protein levels in mammalian bodily fluids can be indicators of disease.
The ability to detect these proteins in samples of various mammalian urine is disclosed herein. Bovine serum albumin is used as a representative protein to evaluate the various detection embodiments disclosed herein. The methods of the present invention are effective for detecting protein in urine samples from mammals, e.g., humans, felines, canines, and rodents. The animal litter disclosed herein could be used for common pets, cats, dogs, gerbils, guinea pigs, mice and hamsters, rabbits, ferrets and laboratory animals (e.g., mice, rats, and the like).
100111 Disclosed herein is the use of Phloxine B, i.e., Acid Red 92 (CAS NO.
87-2, C2oH2Br4Cl 4Na2O5. MOL WT. 829.64), hereinafter referred to as Phloxine, as a protein detector. Phloxine is a pH indicator that undergoes a visual color change based on it's pKa. Referring to FIG. 1, Phloxine goes from colorless (left) to red (right) between about pH 2-3.3, i.e., Phloxine is colorless below about pH 2, red above about pH 3.3 and varying shades of pink (pale to dark) between about pH
2-3.3.
FIG. 2 shows a mechanism by which Phloxine attaches to protein thereby causing a color change from colorless (unbound) to red (bound) without a pH change. The pKa of unbound Phloxine occurs at about pH 2.8-2.9, if Phloxine is bound to a protein, the pKa shifts to the lower pH value of about 2 -2.2. In a buffered system, this pKa shift changes the color of the indicator without a commensurate change in the pH.
Unbound Phloxine will appear colorless at pH levels between about 2.3-3, whereas The Clorox Company 2 430.204 " CA 02552112 2006-07-12 [0012] Phloxine bound to protein will appear pink at pH levels between about 2.3 - 3.
Thus, buffering a sample at a pH below about 3 and contacting that sample with Phloxine enables the presence of protein to be detected in the sample via a color change from colorless to red. Optimally, the final combination of sample and Phloxine will result in a pH between about 2 and 2.5. Thus, depending on the conditions surrounding the Phloxine, the optimal buffering pH may vary, but should be below about 3.
[0013] Colorless to red as used herein means colorless to the entire spectrum of pink and red, including any and all shades of pink and red. Red shade color shifts are also possible if the starting color is something other than colorless. For example, if the starting color is blue, a red shade color shift to purple would be observed.
Test strips containing Phloxine can be prepared by wetting a suitable paper substrate with a Phloxine solution and drying. Such test strips would be useful to those in the medical field.
Detection of protein in feline urine [0014] Disclosed herein is the incorporation of a health indicating system into an animal litter. Animal litters have been used for decades as an effective way of managing the sanitation and odor control of waste. Since animal health monitoring often involves the testing of waste materials from the animal, it would be desirable to combine a health monitoring system with an animal litter. Problems associated with developing such a system are unique in that the animal waste material has to be tested "as is", i.e., without the benefit of any sample preparation or "clean-up".
For example, protein-indicating strips exist, but there are a number of limitations that prevent this technology from being used in an animal litter. Specific limitations with The Clorox Company 3 430.204 .. . , l . , I d ., I =
existing protein-indicating test strips include the following. (1) Stability of the indicator. Many protein-indicating compounds are not stable in the presence of elevated temperature, oxygen or moisture. (2) Stability of the color change.
Many indicators do not hold the color change for long periods or when dry. Thus, a color change may occur without alerting the animal owner. (3) Color contrast. Many indicating systems rely on a subtle shift in the shade of a color, creating a system that is difficult for the user to interpret.
[0015] Accompanying the fact that the waste material must be used "as is", is the fact that feline urine, itself, is unique in several aspects. Feline urine contains high levels of salt. Thus, in inadequately buffered systems, the high salt content and the highly buffering nature of feline urine tends to overwhelm these systems creating numerous false positives. The gradual changes in color that result from inadequately buffered systems are difficult for the user to detect. Furthermore, the urine of healthy cats can contain some protein. Thus, the detection of protein in feline urine can only be an indicator of cat health if (1) normal levels of protein (500 ppm) can be distinguished from disease levels (2000 ppm) and (2) the color change can be easily interpreted.
For applications of Phloxine as an indicator of feline health, color changes from colorless to pink rather than red are preferred by users. Thus, much of the discussion will revolve around systems exhibiting color changes from colorless to pink.
However, it should be noted that, if desired, systems having color changes from colorless to red could readily be designed and substituted for those of colorless to pink.
[0016] Disclosed herein is a stable health indicating system which allows for the detection of protein in feline urine using an easily interpretable colorless to pink color The Clorox Company 4 430.204 . . . , ! .. ,. . ! a i change. Although the disclosure and examples focus on feline urine, as discussed previously, the system is applicable to mammalian urine in general. A protein sequestering agent, e.g., dodecyl(sulfophenoxy)benzenesulfonic acid (hereinafter DSB), is used to inhibit the color change at low levels of protein and allow the color change at higher levels. DSB competes strongly with the Phloxine for active sites on the protein and therefore, if present in a predetermined amount, the level of protein detection can be controlled. Referring to FIG. 3, DSB works by inhibiting the attachment of the Phloxine molecule to the active sites on the protein molecule thereby inhibiting a color change from occurring. Since the sequestering agent is present at a fixed level, it is effective in blocking attachment at low levels of protein, but at higher levels of protein free sites become available for the Phloxine to occupy, thus allowing the color change to occur. Compounds believed to denature proteins (as opposed to binding to them as DSB) could be used in place of the sequestering agent.
Some examples of include Tritari surfactant, Nacconor, and 5-sulfosalicylic acid.
[0017] Stock buffer solutions of citric acid which sometimes also contain sodium citrate (ranging from about 0.5-2.5M citric acid) can be used in preparing phloxine/DSB litter compositions as discussed in the Examples herein. Both Phloxine and DSB are very stable, i.e., no refrigeration is required and shelf life is not limited.
[0018] All or a portion of an absorbent litter material is coated or imbedded with the Phloxine/protein sequestering agent composition described. The Phloxine/protein sequestering agent composition can be added to the litter as a liquid spray, a powder coating or ingredient, a precoated particle, a speckle, or as part of an agglomerate litter. Suitable absorbent litter materials include minerals, fly ash, absorbing pelletized materials, perlite, silicas, other absorbent materials and mixtures thereof.
The Clorox Company 5 430.204 . .,l . , . ..I . ,.~. .. 4 , = CA 02552112 2006-07-12 Preferred minerals include: bentonites, zeolites, fullers earth, attapulgite, montmorillonite diatomaceous earth, opaline silica, Georgia White clay, sepiolite, calcite, dolomite, slate, pumice, tobermite, marls, attapulgite, kaolinite, halloysite, smectite, vermiculite, hectorite, Fuller's earth, fossilized plant materials, expanded perlites, gypsum and other similar minerals and mixtures thereof. The absorbent materials can be further processed, for instance by agglomeration. The lower the intrinsic pH of the substrate, the lower the amount of buffering agent needed.
Thus, substrates having intrinsically low pHs relative to other substrates are preferred.
When contacted with the animal urine, the Phloxine/protein sequestering agent composition changes to a color in the presence of high levels of protein and stays colorless in the absence of protein or in the presence of low levels of protein.
Additional base colorants can be added to create a color change from one color to another color of a redder shade (e.g., blue to purple, etc.). Filler materials such as limestone, sand, calcite, dolomite, recycled waste materials, zeolites, and gypsum can also be incorporated with the absorbent materials to reduce the cost of the litter without significantly decreasing the material's perfonmance as a health indicating litter.
[0019] Partial treatment of the litter can be accomplished by incorporating "treated speckles" into the base litter composition. Some problems associated with identifying effective speckle formulations include lack of color development, spontaneous color change, or bleeding of color. Effective speckle materials have the following properties: (1) Porous and rapidly absorbent; (2) Able to hold a high salt load; (3) Moderate surface area (about 25-300 m2/g) and large pore size (greater than 400A);
(4) Moderate surface acidity (pH between about 1-7) (5) Light color.
Presumably, the The Clorox Company 6 430.204 4 ..,, ... ..I ,..4.... i.
high buffer loading and the rapid absorptivity allows for less influence from outside the particle. One material which fit the above-listed criteria is large pore size silica gel or Type MB macroporous silica gel. For example, a suspension of Phloxine B
indicator, buffered at a pH of 2.1, with a trace of Rhodocal DSB-85, can be sprayed at a high loading rate (e.g., 20% or greater) onto Type MB Macroporous silica gel to form a "treated speckle". Incorporation of "treated speckles" into high pH
clays such as bentonite can be accomplished, but care should be taken to avoid the Phloxine bleeding out of the speckle particles and turning red upon contact with the bentonite.
For example, the litter can be layered to ensure that the Phloxine is bound up in an immobile layer, such as guar gum. Alternatively, a polymeric non-leaching indicator can be used in place of the Phioxine.
100201 Non-litter applications of the combination of Phloxine/protein sequestering agent are also disclosed herein. For example, test strips containing Phloxine and DSB
can be prepared and would be useful to those in the human or veterinarian medicine fields.
[0021] The following examples illustrate the present invention. The examples are for illustrative purposes only and are not meant to limit the scope of the invention in any way.
EXAMPLES
Materials [0022] Bovine serum albumin (BSA) was obtained from either EMD Pharmaceuticals or Calbiochem was used as the protein detected in all examples listed below.
BSA/water and BSA/urine standards were prepared. The urine used in BSA/urine standards was first treated by removing the native protein by precipitation with sulfosalicylic acid and filtration.
The Clorox Company 7 430.204 [0023] Phloxine was obtained from Aldrich Chemical. One percent phloxine solutions were prepared by dissolving phloxine in a small amount of methanol and then diluting with water.
[0024] The DBS used was Rhodacal DSB-85.
[0025] Stock buffer solutions of citric acid and sodium citrate can be used in preparing the phloxine/DSB litter compositions. For example, a buffer solution was prepared by adding citric acid to water and measuring the pH. Sodium citrate was then added to the citric acid solution, if necessary, until the pH reached the desired number.
Example 1(Preparation of silica gel litter and speckles) [00261 A Phloxine/Citric Acid/DSB solution comprising 0.1 % Phloxine, 0.05%
Rhodacal DSB-85, and the remainder 2M citric acid buffered with sodium citrate (adjusted to pH 2.15) was dripped on about lOOg of Macropore B silica gel until the absorption capacity of the silica gel was reached. The Phloxine/DSB-treated silica gel was then air-dried.
Example 2(Prenaration of a clumping Georgia White C1a~GWC) litter) [0027] SamQle 2A- 4g of a 1% phloxine solution and 0.077g DSB were combined with 150g of citric acid buffer (2M, pH 2). 35g were applied to 50g of GWC
using a spray gun.
[0028] Sample 2B- 2.7g of the 1% phloxine solution were added to the solution prepared in Sample A to increase the phloxine concentration to 5%. 35g of this solution were applied to 50g GWC using a spray gun.
100291 Sample 2C- 2g of the 1% phloxine solution were added to the solution prepared in Sample B to increase the phloxine concentration to 7.5%. 35g of this solution were applied to 50g GWC using a spray gun.
[0030] Sample 2D- 1.125g of the 1% phloxine solution were added to the solution prepared in Sample C to increase the phloxine concentration to 10%. 35g of this solution were applied to 50g GWC using a spray gun.
The Clorox Company 8 430.204 [0031] The GWC samples were allowed to dry for 2 days and then were tested with BSA/urine standards containing varying amounts of protein. The results are compiled in Table 1.
Table 1 700ppm BSA/urine 1200ppm BSA/urine 3200ppm BSA/urine Sample 2A off-white off-white light pink Sample 2B off-white light pink Pink Sample 2C off-white light pink Pink Sample 2D off-white light pink Pink Example 3(Preparation of silica gel litter with health indicating ipeckels) [0032] Type C silica gel with about 5% health indicating speckles was prepared and tested. Macropore B silica gel was prepared as described in Example 1 and then added to a commercial Type C silica gel litter material.
Example 4(Preparation of clay litter with health indicating speckels) [0033] A bentonite clay litter with about 3% health indicating speckles was prepared and tested. Macropore B silica gel was prepared as described in Example 1 and then added to a commercial bentonite litter material.
Example 5 (Detection of protein when contacted with sample litter) [0034] The litter sample prepared in Example 3 was placed in a tray and tested with 2 ml of base urine (low protein) and 2 ml of 10K (theoretical), 3-5K (as analyzed) BSA/urine. The samples were evaluated after 4 hours and after 24 hours. The speckles contained in the section of sample tested with base urine remained white after 4 hours and remained unchanged after 24 hours. The speckles contained in the section of sample tested with a BSA/urine standard showed a pink hue after 4 hours and remained unchanged after 24 hours.
[0035] Another sample as described in Example 3 was prepared with a larger quantity of urine, about 5 ml, and allowed to stand for one week. The speckles contained in the section of sample tested with base urine remained white. The speckles contained The Clorox Company 9 430.204 ,,l ..,,, ,.,I ,a = e CA 02552112 2006-07-12 in the section of sample tested with a BSA/urine standard contained regions of light pink and regions of bright pink. In all cases, the color was stable with little to no bleeding.
Example 6 (Detection of protein when contacted with sample litter) [0036] The sample litter prepared in Example 4 was placed in a tray and tested with 5 ml of base urine (low protein) and 5 ml of 10 K (theoretical), 3-5K (as analyzed) BSA/urine. The samples after 4 hours and after 24 hours. The speckles contained in the section of sample tested with base urine showed regions of white and pink after 4 hours and remained unchanged after 24 hours. The speckles contained in the section of sample tested with a BSA/urine standard showed a few regions of white, some regions of light pink and some regions of darker pink after 4 hours and remained unchanged after 24 hours. Due to the high alkalinity of bentonite clay, some bleeding of color was expected to occur. Thus, the speckles were only partially successful in avoiding the influence of surrounding material.
Example 7(prenaration of agglomerated health indicating clav liter) [0037] 9.1 lbs of paste was prepared by mixing 7.81bs of guar gum and 1.3 lbs of citric acid, anhydrous and a small amount of water necessary to facilitate mixing. The paste was added to a mixture of 69.91bs of Tennessee #10 Clay, 18.2 lbs of Kentucky Stone Clay, 2.71bs of citric acid (anhydrous), and 0.10 lbs Phloxine to form a litter mixture. Other similar clay materials could be substituted for the Tennessee #10 Clay and the Kentucky Stone Clay. The litter mixture was agglomerated through extrusion (or other agglomeration means) to form an agglomerated health indicating litter material.
[00381 It is to be understood that the invention described herein is not limited to particularly exemplified systems or process parameters as such may, of course, vary.
It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments of the invention only, and is not intended to limit the scope of the invention in any manner.
The Clorox Company 10 430.204 .l .. .,. .~I .~ _.. 4 = . CA 02552112 2006-07-12 [0039] All publications, patents and patent applications cited herein, are hereby incorporated by reference in their entirety to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference.
[0040] It must be noted that, as used in this specification and the appended claims, the singular forms "a," "an" and "the" include plural referents unless the content clearly dictates otherwise. Thus, for example, reference to a "buffering agent"
includes two or more such agents.
[0041] All numbers expressing quantities of ingredients, constituents, reaction conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term "about". Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the subject matter presented herein are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contain certain errors necessarily resulting from the standard deviation found in their respective testing measurements.
[0042] A number of methods and materials similar or equivalent to those described herein can be used in the practice of the present invention. Many modifications and variations are possible in light of the above teaching.
The Clorox Company 11 430.204
Claims (20)
1. An animal litter additive comprising:
MB Macroporous silica gel buffered at a pH below about 3 containing a mixture of a protein-sequestering agent and Phloxine, wherein said protein-sequestering agent is present in an amount effective at blocking the attachment of Phloxine to protein at a predetermined protein level.
MB Macroporous silica gel buffered at a pH below about 3 containing a mixture of a protein-sequestering agent and Phloxine, wherein said protein-sequestering agent is present in an amount effective at blocking the attachment of Phloxine to protein at a predetermined protein level.
2. The animal litter additive recited in claim 1, wherein said protein sequestering agent is dodecyl(sulfophenoxy)benzenesulfonic acid.
3. A protein detection method comprising:
providing a sample;
contacting said sample with Phloxine; and detecting the presence of protein in said sample, wherein a color change is observed if said sample contains said protein.
providing a sample;
contacting said sample with Phloxine; and detecting the presence of protein in said sample, wherein a color change is observed if said sample contains said protein.
4. The method recited in claim 3, wherein the color change is a red shift.
5. The method recited in claim 3, wherein the Phloxine is buffered below a pH
of about 3.
of about 3.
6. The method recited in claim 3, further comprising the step of contacting said sample with a protein sequestering agent concurrent with the step of contacting said sample with Phloxine.
7. The method recited in claim 6, wherein said protein-sequestering agent is dodecyl(sulfophenoxy)benzenesulfonic acid (DSB).
8. The method recited in claim 3, wherein said contacting is accomplished by a test strip.
9. The method recited in claim 5, wherein said Phloxine is buffered using a weak acid and optionally a corresponding salt.
10. The method recited in claim 9, wherein said Phloxine is buffered using citric acid and optionally sodium citrate.
11. The method recited in claim 6, wherein the protein-sequestering agent is present in an amount effective at blocking the attachment of Phloxine to protein at a predetermined protein level.
12. The method recited in claim 11, wherein said predetermined protein level is between 500-2,000 ppm.
13. The method recited in claim 11, wherein said predetermined protein level is greater than 2,000 ppm.
14. The method recited in claim 3, wherein said sample is a urine sample.
15. The method recited in claim 14, wherein said urine is mammalian urine.
16. The method recited in claim 15, wherein said mammalian urine is human, canine, feline, equine, bovine, lupine or rodent.
17. An animal litter comprising:
an absorbent material suitable for use as an animal litter, wherein at least a portion of said litter contains Phloxine, wherein said Phloxine-containing portion of litter is below about pH 3.
an absorbent material suitable for use as an animal litter, wherein at least a portion of said litter contains Phloxine, wherein said Phloxine-containing portion of litter is below about pH 3.
18. The animal litter recited in claim 17, wherein said absorbent material is selected from the group consisting of bentonites, zeolites, fullers earth, attapulgite, montmorillonite diatomaceous earth, opaline silica, Georgia White clay, sepiolite, calcite, dolomite, slate, pumice, tobermite, marls, attapulgite, kaolinite, halloysite, smectite, vermiculite, hectorite, Fuller's earth, fossilized plant materials, expanded perlites, gypsum and mixtures thereof
19. The animal litter recited in claim 17, further comprising a predetermined amount of a protein-sequestering agent wherein the predetermined amount of protein-sequestering agent is the amount effective at blocking the attachment of Phloxine to protein at a predetermined protein level.
20. The animal litter recited in claim 19, wherein the protein-sequestering agent is dodecyl(sulfophenoxy)benzenesulfonic acid (DSB).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2552112A CA2552112C (en) | 2006-07-12 | 2006-07-12 | Protein detection system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2552112A CA2552112C (en) | 2006-07-12 | 2006-07-12 | Protein detection system |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2552112A1 true CA2552112A1 (en) | 2008-01-12 |
CA2552112C CA2552112C (en) | 2013-12-24 |
Family
ID=38920805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2552112A Active CA2552112C (en) | 2006-07-12 | 2006-07-12 | Protein detection system |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2552112C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116953258A (en) * | 2023-08-02 | 2023-10-27 | 山东瑞达硅胶有限公司 | Pet urine protein detection particle and preparation method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230309502A1 (en) * | 2022-02-17 | 2023-10-05 | Controlled Release Technologies, Inc. | Animal litter compositions and method of ammonia abatement |
-
2006
- 2006-07-12 CA CA2552112A patent/CA2552112C/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116953258A (en) * | 2023-08-02 | 2023-10-27 | 山东瑞达硅胶有限公司 | Pet urine protein detection particle and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CA2552112C (en) | 2013-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7485466B2 (en) | Protein detection system | |
US20050145186A1 (en) | Animal litter | |
US5860391A (en) | Absorbents containing activated carbons | |
EP2091322B1 (en) | Clump recognition animal litter | |
US20070017453A1 (en) | Animal litter containing activated carbon | |
CA1246848A (en) | Animal litter | |
US8230811B2 (en) | Animal litter | |
US7533630B2 (en) | Animal litter having the property of detecting diabetes in felines | |
CA3019331C (en) | Water-absorbing material and uses thereof | |
US5371054A (en) | Compositions for use as diagnostic animal litter and methods for their preparation | |
US6308658B1 (en) | Animal litter having the property of detecting urinary infection in felines | |
CA2635301A1 (en) | Waste encapsulating animal litter | |
US6019062A (en) | Animal litter | |
CA2552112C (en) | Protein detection system | |
US5996534A (en) | Animal litter having the property of detecting urinary infection in felines | |
US20080295778A1 (en) | Animal litter with colorimetric indicator | |
US11767307B2 (en) | Litter for promoting pet's in-litter elimination | |
JP3169386U (en) | Animal toilet grain | |
JPH09248087A (en) | Urination treatment sand | |
JP3154924U (en) | Animal toilet grain | |
WO2018175509A1 (en) | Methods and composition for suppression of ammonia formation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |